Wie lange wirkt Daratumumab?
70 % der Patienten, die Darzalex und Dexamethason plus Lenalidomid erhielten, lebten 36 Monate ohne Fortschreiten der Erkrankung, im Vergleich zu 39 % der Patienten, die Dexamethason und Lenalidomid erhielten.
Was ist Daratumumab Chemotherapie?
Daratumumab ist der erste monoklonale Antikörper, der zur Behandlung des Multiplen Myeloms eingesetzt wird. Der Antikörper bindet an das Oberflächenprotein CD38, das von den Tumorzellen in allen Stadien der Erkrankung gebildet wird.
How long does remission last for multiple myeloma?
Every patient wonders how long that remission will last, but there is no simple formula and every patient is different. It can depend on the type of myeloma treatment you receive, the genetics of your myeloma and other health factors. It is common for myeloma to return after an initial remission.
Is there such a thing as relapsed multiple myeloma?
It can depend on the type of myeloma treatment you receive, the genetics of your myeloma and other health factors. It is common for myeloma to return after an initial remission. This is called relapsed multiple myeloma. The goal of today’s treatment is to extend the length and depth of remissions until a cure can be found.
Is it possible for myeloma to go back to normal?
In myeloma it typically does not. Though we love the word remission, we hesitate because myeloma is known to come back after some time. A patient is always on the fence of living the life of past normalcy and that of remission.
What’s the goal of treatment for multiple myeloma?
As seen at the beginning of this module, the goal of treatment is always control the disease, its effects on the body, and extend the maximum duration of complete or partial remission time. The goal of treatment is always control the disease, its effects on the body, and extend to the maximum time duration of complete or partial remission.